Exclusive

Publication

Byline

Ono Pharma's Opdivo intravenous infusion wins additional approval in Taiwan

Singapore, Aug. 20 -- Japan-based Ono Pharmaceutical has announced that Ono Pharma Taiwan, a Taiwanese subsidiary of Ono, has received the additional approval of OPDIVO(R) Intravenous Infusion, an ant... Read More


Japan's Chugai Pharma signs exclusive license agreement with GSK for anti-dengue virus antibody AID351

Singapore, Aug. 20 -- Japan-based Chugai Pharmaceutical has signed an exclusive license agreement with British pharma firm GlaxoSmithKline (GSK) for the anti-dengue virus antibody "AID351". Under thi... Read More


Korean medtech player Rayence launches portable X-ray diagnostic solutions

Singapore, Aug. 20 -- Rayence, a South Korea-based leader in digital X-ray detectors and medical imaging solutions, has announced the launch of its next-generation portable X-ray as diagnostic solutio... Read More


Mankind Pharma inks diabetes deal with Chongqing Chenan Biopharma

Singapore, Aug. 20 -- Mankind Pharma, one of India's leading pharmaceutical companies, has entered into an exclusive in-licensing and marketing agreement with Chongqing Chenan Biopharmaceutical, China... Read More


Brown University Health and Arcamyra to launch Phase I trial of ACM-CpG in peritoneal carcinomatosis

Singapore, Aug. 20 -- Brown University Health and Arcamyra Therapeutics are preparing to launch a Phase I clinical trial of ACM-CpG in patients with peritoneal carcinomatosis following US Food and Dru... Read More


Singapore approves GSK's Blenrep combinations for treatment of relapsed/refractory multiple myeloma

Singapore, Aug. 19 -- GSK Singapore has announced that the Singapore Health Sciences Authority (HSA) has approved Blenrep for the treatment of adults with relapsed or refractory multiple myeloma in co... Read More


Andelyn Biosciences partners Queen's University on AAV9-GM2 gene therapy manufacturing

Singapore, Aug. 19 -- Andelyn Biosciences has partnered with Queen's University to develop and manufacture AAV9-GM2, an investigational gene therapy for GM2 gangliosidoses, including Tay-Sachs and San... Read More


CanSinoBIO's Td5cp adolescent and adult vaccine NDA accepted in China

Singapore, Aug. 19 -- CanSino Biologics has announced that China's National Medical Products Administration has accepted the New Drug Application for its Tetanus, Reduced Diphtheria and Pertussis (Ace... Read More


LEO Pharma buys Tanabe's rare disease drug dersimelagon for $435 M

Singapore, Aug. 18 -- LEO Pharma, a global leader in medical dermatology delivering innovative solutions for skin disease, has entered into an agreement to acquire worldwide rights to dersimelagon fro... Read More


Lonza launches rapid custom media prototyping service for early bioprocess development

Singapore, Aug. 18 -- Switzerland-based Lonza, the world's leading contract development and manufacturing organization (CDMO), has announced its Rapid Media Prototyping Service (RaMP), giving biopharm... Read More